Si-Bone (SIBN) Net Income Growth (1y) (2018 - 2026)
Si-Bone (SIBN) Net Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -30.10% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | - |
| 10 | Si-Bone | 658.74 Mn | 518.61 Mn | 41.94 Mn | 33.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.82% |
| Dec 31, 2025 | 63.45% |
| Sep 30, 2025 | 31.04% |
| Jun 30, 2025 | 31.23% |
| Mar 31, 2025 | 39.41% |
| Dec 31, 2024 | 59.68% |
| Sep 30, 2024 | 33.38% |
| Jun 30, 2024 | 20.37% |
| Mar 31, 2024 | 3.46% |
| Dec 31, 2023 | 2.26% |
| Sep 30, 2023 | 29.31% |
| Jun 30, 2023 | 38.85% |
| Mar 31, 2023 | 35.47% |
| Dec 31, 2022 | 21.00% |
| Sep 30, 2022 | 11.62% |
| Jun 30, 2022 | -31.25% |
| Mar 31, 2022 | -37.99% |
| Dec 31, 2021 | -62.92% |
| Sep 30, 2021 | -64.98% |
| Jun 30, 2021 | -12.01% |